Filing Flows › InspireMD (NSPR) › Q2 2026 › vs Q1 2026
InspireMD (NSPR) Q2 2026 vs Q1 2026 (quarter over quarter)
InspireMD's revenue fell $1.6M (-48%) from $3.4M in Q1 2026 to $1.8M in Q2 2026.
InspireMD, Q2 2026: revenue $1.8M (-0.4% year over year), operating margin -815.6%, net loss $14.3M, operating cash flow −$10.9M. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $1.8M | $3.4M | −$1.6M | -48% |
| Other income, net | $121K | $289K | −$168K | -58% |
| Net loss | $14.3M | $13.7M | $635K | +5% |
| Costs & expenses | $16.2M | $17.4M | −$1.2M | -7% |
| Operating costs | $16.2M | $17.4M | −$1.2M | -7% |
| Research & development | $4.3M | $4.8M | −$468K | -10% |
| Sales & marketing | $5.2M | $5.2M | $41K | +0.8% |
| General & admin | $4.2M | $4.7M | −$567K | -12% |
| Operating cash sources | $14.3M | $13.7M | $635K | +5% |
| Depreciation | $158K | $149K | $9K | +6% |
| Share-based compensation | $2.2M | $2.1M | $113K | +5% |
| Working capital & other | $1.1M | −$902K | $2.0M | — |
| Cash used in operations | $10.9M | $12.3M | −$1.4M | -12% |
| Net loss absorbed | $14.3M | $13.7M | $635K | +5% |
Questions
How much did InspireMD's revenue grow quarter over quarter in Q2 2026?
InspireMD's revenue fell $1.6M (-48%) from $3.4M in Q1 2026 to $1.8M in Q2 2026.